A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Item

http://www.wikidata.org/entity/Q35294575

Q35294575

about

CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning Update on Imaging of Ovarian Cancer Role of aggressive surgical cytoreduction in advanced ovarian cancer Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care The role of surgery in advanced epithelial ovarian cancer Robotic surgery for ovarian cancers: individualization of the surgical approach to select ovarian cancer patients.Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Risk stratification and outcomes of women undergoing surgery for ovarian cancer Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma.A framework for a personalized surgical approach to ovarian cancer.A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer Radical surgery in ovarian cancer.Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients.Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.Preoperative hyponatremia in women with ovarian cancer: An additional cause for concern?E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.Ovarian cancer: imaging in treatment selection and planning with FIGO update.Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.Neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Who really benefits?Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Advanced Primary Epithelial Ovarian and Peritoneal Carcinoma-Does Diagnostic Accuracy of Preoperative CT Scan for Detection of Peritoneal Metastatic Sites Reflect into Prediction of Suboptimal Debulking? A Prospective Study.A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study

P2860

Q26739931-459DCB21-85EB-42EA-ADB1-6F7DB3E759C6 Q26750610-DCB311DA-2CA7-4416-99AC-D8A2313BE136 Q26801358-29108DE2-4C86-4956-9159-14D665526AB3 Q26828510-235F1F70-2065-45C4-AE24-43B7916DB167 Q28067698-F3C7C192-E423-4A77-BD90-702D4BBFA512 Q30252115-115DC21E-710F-4BE2-919E-FAC0F2314676 Q30717971-17DEA046-5A07-4B5F-B008-39B228CB8270 Q33626973-90E4DC96-BC16-4E3D-8A00-D30BF7C1BF2A Q35748533-1C27F258-D9B8-457D-BF26-D6A126E82225 Q35812813-1B61697C-0B38-49DF-A439-39C32D505683 Q35926352-0281330D-1C2A-4AB0-A426-D0CAD539E856 Q36372816-D604450A-3514-4446-9885-0F734C08595A Q36834937-53AC277A-2D7F-470E-B700-A881B7F2C51C Q37290454-32A9E55B-5006-453E-A69F-349C10704C8C Q38364615-56FC59BA-28E4-40AA-B094-09D8919729D4 Q38569619-4417E803-F39B-461D-92C2-D0244AE580AE Q38791320-73CB6EAF-1353-4B9F-B911-77B21C82F1B4 Q39382941-8BA60C79-02B4-42A1-B4C3-0D4587A958F7 Q40331453-E87067EB-83F7-4E65-9581-B879843D8FD3 Q40387712-5E9FBCE3-BB09-4C9F-8D61-DEDE7F44C48B Q42362054-4DD3785A-AB82-474F-9579-0283BB70A562 Q44223057-2FF84B68-4C96-4F61-80F0-8592D5D23A06 Q46325180-7229CDA1-0A97-40AD-86D1-93FF5B5471E9 Q46759110-8893AAAD-C95F-4616-BF58-7A91E292E02C Q48008944-F8178534-59F0-4471-8833-22A302AE258A Q50054786-B6A52437-9306-4BBC-AA55-0063F4D29D96 Q53054061-E6B52598-8549-4E5E-ADDA-0E9ED0C264CD Q54047420-35947ABD-EEC3-42BE-8CDB-4AC641CFDE68 Q55302464-12F0EB10-B14E-487D-8B79-C4C61ABEED82 Q57164774-82097A6B-5DF6-434B-BBC7-8BF7DF65D7C2

P2860

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Item

http://www.wikidata.org/entity/Q35294575

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu